Nucleocapsid Antigenemia in Patients Receiving Anti-CD20 Therapy With Protracted COVID-19

Eli Wilber,Anne Piantadosi,Ahmed Babiker,Kaleb McLendon,William O'Sick,Eric Fitts,Andrew S Webster,Hans Verkerke, James S Kim,Varun K Phadke,Nadine Rouphael,Boghuma K Titanji, William T Blake,Jessica Howard-Anderson,John D Roback,Wilbur A Lam,Gregory L Damhorst

OPEN FORUM INFECTIOUS DISEASES（2022）

引用 3|浏览11

暂无评分

摘要

Immunocompromised patients with prolonged coronavirus disease 2019 symptoms present diagnostic and therapeutic challenges. We measured viral nucleocapsid antigenemia in 3 patients treated with anti-CD20 immunotherapy who acquired severe acute respiratory syndrome coronavirus 2 infection and experienced protracted symptoms. Our results support nucleocapsid antigenemia as a marker of persistent infection and therapeutic response.

查看译文

关键词

SARS-CoV-2, antigenemia, diagnostics, immunocompromised

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要